v3.26.1
Stockholders’ Deficit (Tables)
6 Months Ended
Jun. 30, 2026
Equity [Abstract]  
Schedule of Stock Based Compensation Expense Recognized for Officer and Director Arrangements

The following table summarizes stock-based compensation expense recognized for all officer and director arrangements for the six months ended June 30, 2026 and 2025:

  

   June 30, 2026   June 30, 2025 
Chief Executive Officer  $657,900   $- 
Chief Financial Officer   -    239,540 
Board of Directors   110,208    95,006 
Total  $768,108   $334,546 
Schedule of Non-vested Shares Related Parties

The following is a summary of the Company’s non-vested shares at June 30, 2026 and December 31, 2025.

 

       Weighted Average 
Non-Vested Shares  Number of Shares   Grant Date Fair Value 
Balance - December 31, 2024   139,640   $5.03 
Granted   150,000    3.16 
Vested   (88,880)   4.77 
Cancelled/Forfeited   -    - 
Balance - December 31, 2025   200,760    4.00 
Granted   945,537    0.40 
Vested   -      
Cancelled/Forfeited   -      
Balance - June 30, 2026   1,146,297   $1.03 
           
Unrecognized Compensation  $772,054      
           
Weighted average period (years)   2.51      
Schedule of Stock Option Transactions

Stock option transactions for the six months ended June 30, 2026 and the year ended December 31, 2025 are summarized as follows:

 

           Weighted       Weighted 
           Average       Average 
       Weighted   Remaining   Aggregate   Grant 
   Number of   Average   Contractual   Intrinsic   Date 
Stock Options  Options   Exercise Price   Term (Years)   Value   Fair Value 
Outstanding - December 31, 2024   1,166,081   $2.37    6.85   $-      
Vested and Exercisable - December 31, 2024   1,166,081   $2.37    6.85   $-      
Granted   1,144,116   $1.75             $1.49 
Exercised   -   $-                
Cancelled/Forfeited   (17,253)  $1.78                
Outstanding - December 31, 2025   2,292,944   $2.06    6.43   $-      
Vested and Exercisable - December 31, 2025   2,292,944   $2.06    6.43   $-      
Granted   -   $-             $- 
Exercised   -   $-                
Cancelled/Forfeited   (424,476)  $2.41                
Outstanding - June 30, 2026   1,868,468   $1.98    5.97   $-      
Vested and Exercisable - June 30, 2026   1,868,468   $1.98    5.97   $-      
Schedule of Fair Value of Stock Options

The fair value of these stock options was determined using the Black-Scholes option pricing model with the following inputs:

 

Expected term   7 years 
Expected volatility   103%
Expected dividends   0%
Risk free interest rate   3.88%
Schedule of Warrants Activity

Warrant activity for the six months ended June 30, 2026 and the year ended December 31, 2025 are summarized as follows:

 

Warrants 

Number of

Warrants

  

Weighted

Average

Exercise Price

  

Weighted

Average

Remaining Contractual

Term (Years)

  

Aggregate

Intrinsic Value

 
Outstanding - December 31, 2024   96,000   $4.73    0.37   $- 
Vested and Exercisable - December 31, 2024   96,000   $4.73    0.37   $- 
Granted   730,000   $5.86           
Exercised   -   $-           
Cancelled/Forfeited   (96,000)  $4.73           
Outstanding - December 31, 2025   730,000   $5.86    4.30   $- 
Vested and Exercisable - December 31, 2025   730,000   $5.86    4.30   $- 
Granted   720,000   $1.26           
Exercised   -   $-           
Cancelled/Forfeited   -   $-           
Outstanding - June 30, 2026   1,450,000   $3.57    4.30   $- 
Vested and Exercisable - June 30, 2026   1,450,000   $3.57    4.30   $-